Public Health Landscape
HIV and cervical cancer remain serious public health challenges. CDC and partners work with the Government of Mozambique to strengthen and expand its response to the HIV epidemic. In 2016, Mozambique had 83,000 new HIV infections and 1,800,000 people living with HIV, among whom 54% were accessing antiretroviral therapy, according to UNAIDS.org.* Quick facts related to the public health landscape in Mozambique are highlighted below, as retrieved from the “CDC Division of Global HIV & TB Country Profile” (July 2018) and the “World Health Organization Cancer Country Profile (2014).”
- – Estimated HIV prevalence (ages 15-49): 12.3% (2016)
- – Estimated AIDS deaths (all ages): 62,000 (2016)
- – Estimated orphans due to AIDS: 1,200,000 (2016)
- – Reported number receiving antiretroviral therapy (ages 15 and above): 914,000 (2016)
Cervix Uteri Cancer:***
- – Female cancer mortality profile: 45.5% (2014)
- – Female cancer incidence: 5,622 (2014)
Cardno’s Contribution to PEPFAR Goals
In an effort to combat the epidemic, Cardno’s P4 Project (and many others) partnered with the Pink Ribbon Red Ribbon Mozambique Partnership to increase demand and access to quality cervical cancer screening and prevention services to women, especially those living with HIV/AIDS in target regions. The partnership also supports procurement of commodities and supplies and capacity building of health workers.
In addition, the P4 Project also partnered with the Open Health Information Exchange Partnership to increase the use of ICT in providing new possibilities to solve public health problems. The partnership supported interoperability by creating a reusable architectural framework that introduced a service-oriented approach to leverage health information standards, enabled flexible implementation by country partners, and supported interchangeability of individual components. The partnership reinforced country-led processes to build and deploy interoperable health information systems in low-resource settings to improve health access and quality of care and efficiently increase productivity. The partnership supported the Data for Accountability, Transparency, and Impact (DATIM) system, PEPFAR’s main information system. DATIM is the PEPFAR-specific version of DHIS 2 and was launched for PEPFAR’s Country Operational Plans and the Site Improvement through Monitoring Systems (SIMS). DATIM allows for data entry, analysis, visualization, and export. It provides a dashboard and reports needed to support targeted epidemic response and can potentially integrate Ministry of Health and U.S. Government agency M&E systems. Phase 1 of this multi-country project ran from 2009 to 2015.
In addition to the projects above, in 2007, the Office of the U.S. Global AIDS Coordinator (OGAC) and Becton, Dickinson and Company (BD) combined their respective strengths, experience, methodologies, and resources to pursue a PPP. The BD-PEPFAR Laboratory Strengthening Partnership was coordinated by the International Laboratory Branch of CDC on behalf of OGAC, and supported specific laboratory strengthening projects relevant to TB and HIV/AIDS treatment and care in PEPFAR countries. The partnership was implemented in Ethiopia, Uganda, Mozambique, and South Africa. The partnership concluded its fifth year of implementation in 2012 and OGAC commissioned Cardno to conduct a third-party assessment of the partnership. The assessment documented the value added of the partnership in terms of BD and PEPFAR shared goals and objectives, resources leveraged, and the results achieved through the partnership. The assessment documented potential opportunities for scale-up and replication of such partnerships. Finally, the assessment distilled the lessons learned from the partnership and provided recommendations on how these lessons can be transferred to the partnership’s second phase, Labs for Life, launched at the International AIDS Conference 2012.
* Data retrieved in September 2018 from unaids.org.
**Data retrieved in September 2018 from www.cdc.gov/globalhivtb.
***Data retrieved in September 2018 from www.who.int/cancer/country-profiles.